Kidney Disease Clinical Trials in New York

Showing 461-478 of 478 trials

Are we Loading Our Patients With Sodium During Hemodialysis Treatments?

NCT01454193

The objectives of the data search is to find out if there is correlation between pre, post serum sodium concentration, dialysate sodium concentration, interdialytic weight gain and associated changes in pre and post systolic and diastolic blood pressure, mean arterial pressure, number of blood pressure medications and adherence to 3 times per week dialysis, mortality.

Renal Failure

Renal Research Institute10,000 participantsStarted Jan 2001

New York, New York, United States

COMPLETED< 1 mile

Events Before Death

NCT01329055

Previous studies of the patients treated in RRI clinics suggest that hemodialysis patients undergo a certain consistent predictable pattern at the initiation of dialysis and before death. This pattern can be described as a group of patterns of patients' biological markers over a few months after starting dialysis and several months prior to death. Additional patterns can be observed that occur with changes in seasons or time of day. The aim of this study is to compare these patterns in patients treated in FMC-Asia, FMC-Europe, FMC-South America, and RRI-US populations. Noting that patterns in patient parameters are similar across continents, climates, and geographic variations only further accentuates the importance in the models that can predict patients' survival and provide an opportunity for timely intervention.

End Stage Renal Disease

Renal Research Institute50,000 participantsStarted Jan 2000

New York, New York, United States

COMPLETEDPhase 2< 1 mile

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

NCT00077974

To assess the safety and efficacy of SU011248 in patients with metastatic, refractory renal cell carcinoma

Carcinoma, Renal Cell

Pfizer106 participantsStarted Feb 2004

Duarte, California, United States • Pasadena, California, United States • San Francisco, California, United States +12 more locations

Are we Loading Our Patients With Sodium During Hemodialysis Treatments?

Events Before Death

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

Kidney Disease Trials in Other Cities

Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia

Immune Effects of Vitamin D in Hemodialysis Patients

Optimizing Prograf® Therapy in Renal Transplant Patients

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

YSPSL for Prevention of Delayed Graft Function Part B

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance

A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Other Conditions in New York